account_num,net_change,tag,tag_depth,cik
2149,-33967000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1205,-1119000.0,InvestmentIncomeNonoperating,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1709,398000.0,InterestExpense,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2130,-136000.0,NonoperatingIncomeExpense,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2257,-33569000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1854,398000.0,InterestAndDebtExpense,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2399,6752000.0,IncomeTaxExpenseBenefit,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1912,-26032000.0,NetIncomeLoss,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1077,-26032000.0,ProfitLoss,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2590,-26032000.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2903,-26032000.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
281,16277000.0,ShortTermInvestments,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1494,1758000.0,EquityMethodInvestments,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1626,1758000.0,LongTermInvestments,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1848,1758000.0,LongTermInvestmentsAndReceivablesNet,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1901,38527000.0,DeferredIncomeTaxAssetsNet,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2552,-11590000.0,AccruedLiabilitiesCurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3383,-178000.0,DeferredIncomeTaxLiabilitiesNet,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3494,-15175000.0,OtherLiabilitiesNoncurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3817,197539000.0,TreasuryStockValue,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1820,-40321000.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1557,1758000.0,InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures,6,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1264,-33433000.0,OperatingIncomeLoss,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1563,-924000.0,InvestmentIncomeInterestAndDividend,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1665,-924000.0,InvestmentIncomeNet,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
645,176615000.0,CashAndCashEquivalentsAtCarryingValue,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
577,192892000.0,CashCashEquivalentsAndShortTermInvestments,4,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1079,235000.0,RestrictedCashCurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1549,235000.0,RestrictedCashAndCashEquivalentsAtCarryingValue,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1071,2435000.0,RestrictedCashAndInvestmentsCurrent,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
229,100638000.0,AccountsReceivableNetCurrent,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
207,100638000.0,AccountsNotesAndLoansReceivableNetCurrent,4,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
320,100638000.0,ReceivablesNetCurrent,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3809,-8268000.0,AccumulatedOtherComprehensiveIncomeLossNetOfTax,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1340,-924000.0,InvestmentIncomeInterest,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
144,66182000.0,CostOfRevenue,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1572,706000.0,FinanceLeaseRightOfUseAsset,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
456,241000.0,DepreciationAndAmortization,4,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
581,20056000.0,OperatingCostsAndExpenses,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2004,-390000.0,OtherNonoperatingIncomeExpense,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1478,-785000.0,IncomeLossFromEquityMethodInvestments,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2877,-11590000.0,AccruedIncomeTaxesCurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2841,-11590000.0,TaxesPayableCurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1317,-195000.0,DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1436,-195000.0,GainLossOnDerivativeInstrumentsNetPretax,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1781,-195000.0,NonoperatingGainsLosses,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1025,241000.0,AmortizationOfIntangibleAssets,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
845,241000.0,AmortizationOfDeferredCharges,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
491,19815000.0,ResearchAndDevelopmentExpense,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
707,7109000.0,SellingAndMarketingExpense,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3395,-7225000.0,AccountsPayableAndAccruedLiabilitiesNoncurrent,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
856,2200000.0,RestrictedInvestmentsCurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1716,-195000.0,GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3426,-7225000.0,AccruedIncomeTaxesNoncurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3260,-548577000.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3917,-773656000.0,LiabilitiesAndStockholdersEquity,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
173,-140022000.0,Revenues,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
232,-73840000.0,GrossProfit,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3316,-960191000.0,StockholdersEquity,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3834,-297755000.0,RetainedEarningsAccumulatedDeficit,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3750,-456623000.0,AdditionalPaidInCapital,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3661,-6000.0,CommonStockValue,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3465,-225079000.0,Liabilities,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3645,-119444000.0,LiabilitiesNoncurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3796,-46572000.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3379,-23994000.0,OperatingLeaseLiabilityNoncurrent,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3303,-72872000.0,LongTermDebtAndCapitalLeaseObligations,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3154,-105635000.0,LiabilitiesCurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
597,13483000.0,GeneralAndAdministrativeExpense,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2638,-2168000.0,DebtCurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2347,-88886000.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2089,773656000.0,Assets,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2091,365986000.0,AssetsNoncurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2041,18536000.0,OtherAssetsNoncurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1827,37179000.0,IntangibleAssetsNetIncludingGoodwill,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1368,243479000.0,PropertyPlantAndEquipmentNet,4,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1634,25801000.0,OperatingLeaseRightOfUseAsset,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
868,407670000.0,AssetsCurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
260,103647000.0,InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings,4,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
455,103647000.0,InventoryNet,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2737,-2168000.0,LongTermDebtAndCapitalLeaseObligationsCurrent,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
601,20592000.0,SellingGeneralAndAdministrativeExpense,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1112,40407000.0,OperatingExpenses,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1002,-2000.0,GainLossOnDispositionOfAssets1,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
